AstraZeneca tops quarterly estimates buoyed by cancer drug sales Ruchika Sharma13 Nov 2022 10:00 AM ISTDelaware: AstraZeneca on Thursday topped analysts' expectations for third-quarter profit and revenue, helped by sales of its key cancer drugs, and...
AstraZeneca Tagrisso gets Japanese okay for early-stage EGFR-mutated lung cancer Ruchika Sharma30 Aug 2022 9:45 AM ISTNew Delhi: AstraZeneca's Tagrisso (osimertinib) has been approved in Japan for the adjuvant treatment of patients with epidermal growth factor...
AstraZeneca, Hutchmed begin phase 3 trial of Orpathys, Tagrisso combo in lung cancer patients Ruchika Sharma28 Nov 2021 10:30 AM ISTHong Kong: HUTCHMED (China) Limited and AstraZeneca PLC have initiated SACHI, a China Phase III study of ORPATHYS (savolitinib), an oral, potent, and...
NPPA gets Delhi HC notice on AstraZeneca plea over cancer drug Tagrisso Ruchika Sharma15 July 2021 1:28 PM ISTNew Delhi: The Delhi High Court on Monday issued notice to National Pharmaceutical Pricing Authority (NPPA) and others on AstraZeneca Pharma India's...
NPPA alleges overcharging for cancer drug Tagrisso: AstraZeneca moves Delhi HC against Rs 157 crore demand notice Medical Dialogues Team30 Jun 2021 5:02 PM ISTNew Delhi: AstraZeneca Pharma India has moved the Delhi High Court challenging a demand notice issued by the National Pharmaceutical Pricing Authority...
Delhi HC asks NPPA to reconsider show cause issued to AstraZeneca over cancer drug Tagrisso Medical Dialogues Team16 May 2021 11:00 AM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has been directed by the Delhi High Court to reconsider and issue a fresh order to...
AstraZeneca Pharma India gets marketing nod for cancer drug Tagrisso Ruchika Sharma11 March 2021 1:21 PM ISTOsimertinib has shown to decrease the chances of cancer spreading to the brain & other distant organs.
FDA approves osimertinib for treatment of non-small cell lung cancer Hina Zahid20 Dec 2020 7:45 AM ISTThe U.S. Food and Drug Administration has approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer...
AstraZeneca reports strong drug sales in Q2 amid lockdown Ruchika Sharma31 July 2020 2:13 PM ISTNewer drugs for diabetes, heart conditions and cancer, including its top selling lung cancer drug Tagrisso, performed well in the quarter and...
FDA approves new pill for non-small cell lung cancer Meghna A Singhania15 Nov 2015 3:58 PM ISTU.S. Food and Drug Administration granted accelerated approval for an oral medication to treat patients with advanced non-small cell lung cancer...
